| API | Description | Activity | Recommended Dosage Forms |
|---|---|---|---|
| Aspirin | Enteric Coated Granules | 50% | Combination Tablets |
| Es-Omeprazole | Enteric Coated Granules | 22.5% | Tablets |
| Diclofenac Sodium | Enteric Coated Granules | 50% | Combination Tablets /Capsules |
| Mebeverine | Moisture Barrier Granules | 90% | for Sachet & Tablets |
| Lumefentrine | Moisture Barrier Coating | 22% | Effervescent Sachet / Tablets |
| Ascorbic Acid | Moisture Barrier Coating | 96% | Effervescent Sachet |
| Citric Acid | Moisture Barrier Coating | 96% | Effervescent Sachet |
Products covered by patent rights in a country should be considered as not offered. Final responsibility with respect to third party patent rights in a specific country lies exclusively with the user.